Bristol Myers Squibb buys Nvidia AI system for drug discovery
Bristol Myers Squibb is purchasing an Nvidia DGX SuperPOD built on the chipmaker’s Vera Rubin architecture to support artificial intelligence use across its drug discovery and development operations. The pharmaceutical company said it will be the first life sciences group to acquire a DGX SuperPOD b
Bristol Myers Squibb is purchasing an Nvidia DGX SuperPOD built on the chipmaker’s Vera Rubin architecture to support artificial intelligence use across its drug discovery and development operations. The pharmaceutical company said it will be the first life sciences group to acquire a DGX SuperPOD based on Vera Rubin. Nvidia introduced the architecture earlier this […] The post Bristol Myers Squibb buys Nvidia AI system for drug discovery appeared first on AI News.
Key Takeaways
- •Bristol Myers Squibb is purchasing an Nvidia DGX SuperPOD built on the chipmaker’s Vera Rubin architecture to support artificial intelligence use across its drug discovery and development operations
- •This story was reported by AI News Daily, covering developments in the news space.
- •AI advancements continue to reshape industries — read the full article on AI News Daily for complete coverage.
📖 Continue reading the full article:
Read Full Article on AI News Daily →
